Can joint clinical assessment speed up access to medicines?

The Joint Clinical Assessment (JCA) is a milestone in European health policy, promising a single shared evaluation of the efficacy and safety of new medicines across EU member states. Theoretically, this should mean consistency for innovators and faster access to medicines for patients. But one year on, how is JCA working in practice, and what needs to happen next?    Grace Hampson is joined by Patrick Hopkinson, founder of PHTA Consulting and global market access expert, and Matthias Hofer, Senior Principal Economist at OHE, to take stock of the lessons learned from the first year of JCA, and discuss what’s yet to come.     A Dose of Economics is Grace and the Office of Health Economics (OHE) team thinking out loud — debating the questions that matter most in healthcare policy, resource allocation, and health system decision-making, with the experts doing the work at the highest level. New episodes drop every Tuesday.    If there’s a topic you’d like us to cover, feel free to share your ideas.